Reply to I. Pecora et al

Affiliations

Comment

Teresa Macarulla et al. J Clin Oncol. 2019.

. 2019 Aug 1;37(22):1979.

doi: 10.1200/JCO.19.00697. Epub 2019 Jun 12.

¹ Teresa Macarulla, MD, PhD, Hospital Vall d'Hebron, Barcelona, Spain; and Manuel Hidalgo, MD, PhD, Beth Israel Deaconess Medical Center, Boston, MA.

No abstract available

Comment on

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.
Macarulla T, Pazo-Cid R, Guillén-Ponce C, López R, Vera R, Reboredo M, Muñoz Martin A, Rivera F, Díaz Beveridge R, La Casta A, Martín Valadés J, Martínez-Galán J, Ales I, Sastre J, Perea S, Hidalgo M. Macarulla T, et al. J Clin Oncol. 2019 Jan 20;37(3):230-238. doi: 10.1200/JCO.18.00089. Epub 2018 Dec 4. J Clin Oncol. 2019. PMID: 30523758 Clinical Trial.
Combination Chemotherapy in Patients With Advanced Pancreatic Cancer With an Eastern Cooperative Oncology Group Performance Status of 2: Lights and Shadows of a Frail Route.
Pecora I, Fornaro L, Vasile E, Catanese S, Salani F, Vivaldi C. Pecora I, et al. J Clin Oncol. 2019 Aug 1;37(22):1978-1979. doi: 10.1200/JCO.19.00127. Epub 2019 Jun 12. J Clin Oncol. 2019. PMID: 31188725 No abstract available.